1361110-63-5

Basic information

• Product Name: 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
• Synonyms: 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine;5-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1H-tetrazole;4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
• CAS NO: 1361110-63-5
• Molecular Formula: C₁₆H₂₃BClNO₃
• Molecular Weight: 323.62272
• Mol File: 1361110-63-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 449.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.17±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.93±0.40(Predicted)
• CAS DataBase Reference: 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine(1361110-63-5)
• EPA Substance Registry System: 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine(1361110-63-5)

Safety Data

• Hazardous Substances Data: 1361110-63-5(Hazardous Substances Data)

Usage

General Description

4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine is a chemical compound that contains a morpholine ring structure. It also features a chloride group and a boron-containing aromatic ring. The presence of the boron atom makes this compound useful in certain organic synthesis reactions as a boron source. It is commonly used as a reagent in the formation of carbon-carbon and carbon-nitrogen bonds. Additionally, its structure and reactivity make it a valuable intermediate in the production of pharmaceuticals and agrochemicals. This chemical is important in the field of organic chemistry and chemical synthesis due to its versatility and usefulness in various types of reactions.

Upstream product

• 1272756-07-6 4-(2-chloro-4-bromophenyl)morpholine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1152616-69-7 7-(3-chloro-4-morpholin-4-ylphenyl)-3-(2,2,2-trifluoroethyl)imidazo[1,2-a]pyridine-8-carbonitrile 

Relevant articles and documents

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

Imidazo[1,2-a]pyridines: Orally active positive allosteric modulators of the metabotropic glutamate 2 receptor

Advanced leads of an imidazopyridine series of positive allosteric modulators of the metabotropic glutamate 2 (mGlu2) receptor are reported. The optimization of in vitro ADMET and in vivo pharmacokinetic properties led to the identification of 27o. With g